Articles by Disease (Rhabdomyosarcoma)

Clinical Development of mTOR Inhibitors: A Focus on Lymphoma

Journal: Reviews on Recent Clinical Trials
Volume: 2
Page: 103-110
Author(s): Sonali M. Smith

5-Fluorouracil Derivatives Induce Differentiation Mediated by Tubulin and HLA Class I Modulation

Journal: Medicinal Chemistry
Volume: 3
Page: 233-239
Author(s): Juan A. Marchal, Houria Boulaiz, Fernando Rodriguez-Serrano, Macarena Peran, Esmeralda Carrillo, Celia Velez, Jose Dominguez, Jose A. Gomez-Vidal, Joaquin Campos, Miguel A. Gallo, Antonio Espinosa and Antonia Aranega

Classification of Sarcomas Using Bioinformatics and Molecular Profiling

Journal: Current Pharmaceutical Biotechnology
Volume: 8
Page: 83-91
Author(s): T. A. Dang and T. K. Man

Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation

Journal: Current Pharmaceutical Design
Volume: 13
Page: 687-703
Author(s): Isabel Varela-Nieto, Markus Hartl, Itziar Gorospe and Yolanda Leon

Antibiotic Properties and Applications of Lactoferrin

Journal: Current Pharmaceutical Design
Volume: 13
Page: 801-811
Author(s): Eugene D. Weinberg

Fusions Involving PAX and FOX Genes in the Molecular Pathogenesis of Alveolar Rhabdomyosarcoma: Recent Advances

Journal: Current Molecular Medicine
Volume: 7
Page: 47-61
Author(s): Gabriela E. Mercado and Frederic G. Barr

Novel Therapeutic Approaches Based on the Targeting of Microenvironment-Derived Survival Pathways in Human Cancer: Experimental Models and Translational Issues

Journal: Current Pharmaceutical Design
Volume: 13
Page: 487-496
Author(s): Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Teresa Fulciniti, Maria Teresa Di Martino and Salvatore Venuta